Samsung Bioepis Enters into Commercialization Agreement for Next-Generation Biosimilar Candidates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. NVDA
2. SPCX
3. META
4. MDB
5. KOD
6. USO
7. MU
8. MIRM
9. LLY
10. SPY

Go back to Samsung Bioepis Enters into Commercialization Agreement for Next-Generation Biosimilar Candidates
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 228.69 +1.09 (0.48%)
Previous Close $227.60    52 Week High $333.65 
Open $225.87    52 Week Low $223.02 
Day High $230.49    P/E 29.28 
Day Low $225.51    EPS $7.81 
Volume 1,332,341